| Please select the appropriate firm type below or give a brief explanation if “Other” is selected: |
|
Pharmaceutical Manufactuer
Distributor
Representative Firm
Marketing and Communications
|
|
Other. Please explain below : |
|
| |
Please select the most appropriate one below that fit your explanation.
Product Information. Which one/s of the below is your firm producing / manufacturing?
|
|
Active Pharmaceutical Ingredient
Finished Pharmaceutical Product
Chemicals, etc.
Excipients and/or Pharmaceutical formulations
Natural Extracts |
| |
|
How would you characterize your firm if you had to choose one of the below? |
|
Generic Pharmaceutical
Innovator Pharmaceutical
Biotechnology / Pharma
Biotechnology / Fod
Biotechnology / Industrial
Nanobiotechnology |
|
In Clinical Trials
Phase I
Phase II
Phase III
Phase IV
Contract Manufacturing Organization
Contract Research Organization
Medical Device |
| |
| Does your organization possess manufacturing facilities and/or capabilities? |
(Yes / No) |
|
If you answer “Yes”, please select the most appropriate choice from below. |
|
Analytical Equipment
Automation & Robotics
Batch Systems /Equipment
Clean Room Equipment
Filling Equipment |
|
Filtration/Separation/Purification
Laboratory Products & Equipments
Packaging Equipments & Supplies
Manufacturing Facilities / Equipments |
|
Process Automation and Controls
Process Equipments
Tablet / Capsule Filling machines
RFID |
|
Test & Measurement Devices
Validation |
| |
|
Would you please give as much information as possible when answering the questions below? |
|
1. If you would like to add Turkish market to the target market of your product/s, which one of the services would you consider to outsource (ex: registration, intellectual property rights, feasibility analysis, direct investment, entrepreneurial investment, business plan, branch opening, etc.)? |
|
| |
|
2. Which countries / regions / markets are you currently marketing your products (please give all appropriate answers)? |
|
| |
|
3. When you consider your products (such as; pharmaceuticals, generics, biopharmaceuticals, green biotechnology products, indsutrial/environmental biotechnology products, nutraceuticals, etc.), do your products in the afore mentioned categories (or others if you prefer to share with us) possess the proper registration dossier appropriately prepared pertaining to the rules and regulations widely accepted in international commerce? Especially, if we had to ask for pharmaceuticals and medical devices, are your current registration dossiers in CTD format? If so, which language or which languages are they ready in? |
|
| |
|
4. Are you familiar with EMEA registration process and related requirements? Are you familiar with Turkish registration process and related requirements? (The two have similarities but not necessarily share all the same properties). |
|
| |
The following questions about clinical trials are poised to understand which phase of a clinical trial, if any, your company is at in order to establish a better understanding for new and upcoming products.
5. Are you required to conduct clinical trials for your products in your country / in other markets where your products are distributed? If so, have you conducted clinical trials for your products?
|
|
| |
|
6. Have you been required to conduct clinical trials for your products in EU countries? If so, how successful was the outcome? Please elaborate. |
|
| |
|
7. If none of the above questions are affirmative, are you in the process of conducting clinical trials for your products? |
|
| |
|
8. Answer the following question if your product is a generic pharmaceutical: Do you have bioequivalence studies conducted for your products? If so, is the end result favorable to suggest strongly that your product is bioequivalent to the innovator product? |
|
| |
|
9. Are you confident that your product/s does/do not infringe any patent and/or other applicable intellectual property rights? |
|
| |
|
10. Would your company be interested in co-development of innovative products/services? Does your company have promising ideas which require financial support? |
|
| |
|
We welcome additional information or thoughts. Please do not hesitate to share with us. Thank you. |
|
|
|